Prognostic factors in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004)

被引：1
|
作者：
Huddart, R. [1 ]
Porta, N. [2 ]
Lewis, R. [2 ]
Hendron, C. [3 ]
Hussein, S. [4 ]
James, N. [5 ]
Hall, E. [2 ]
机构：
[1] Inst Canc Res, Sect Acad Radiotherapy, London SW3 6JB, England
[2] Inst Canc Res, Clin Trials & Stat Unit, London SW3 6JB, England
[3] Univ Birmingham, CRCTU, Birmingham, W Midlands, England
[4] Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool L69 3BX, Merseyside, England
[5] Univ Warwick, Canc Studies Unit, Coventry CV4 7AL, W Midlands, England
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31328-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2507
引用
收藏
页码：S475 / S476
页数：3
相关论文
共 50 条
  • [1] The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 (CRUK/01/004) trial
    Ananya, C.
    West, C.
    Porta, N.
    Denley, H.
    Hendron, C.
    Hussain, S.
    Hall, E.
    Huddart, R.
    James, N.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S527 - S528
  • [2] The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004)
    Ananya Choudhury
    Catharine M West
    Nuria Porta
    Emma Hall
    Helen Denley
    Carey Hendron
    Rebecca Lewis
    Syed A Hussain
    Robert Huddart
    Nicholas James
    British Journal of Cancer, 2017, 116 : 649 - 657
  • [3] The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004)
    Choudhury, Ananya
    West, Catharine M.
    Porta, Nuria
    Hall, Emma
    Denley, Helen
    Hendron, Carey
    Lewis, Rebecca
    Hussain, Syed A.
    Huddart, Robert
    James, Nicholas
    BRITISH JOURNAL OF CANCER, 2017, 116 (05) : 649 - 657
  • [4] Quality of life (QL) of muscle invasive bladder cancer (MIBC) patients (pts) receiving radiotherapy (RT) plus /- chemotherapy (CT) in the BC2001 trial (CRUK/01/004)
    Huddart, R.
    Hall, E.
    Miranda, M.
    Crundwell, M.
    Jenkins, P.
    Rawlings, C.
    Tremlett, J.
    Hendron, C.
    Lewis, R.
    Porta, N.
    Hussain, S.
    James, N.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S186 - S187
  • [5] Quality of life (QL) of patients (pts) treated for muscle invasive bladder cancer (MIBC) with radiotherapy (RT) ± chemotherapy (CT) in the BC2001 trial (CRUK/01/004): Analysis of impact of treatment at an individual level.
    Huddart, Robert Anthony
    Hall, Emma
    Miranda, Miguel
    Crundwell, Malcolm
    Jenkins, Peter
    Rawlings, Christine Lisa
    Tremlett, Jean
    Hendron, Carey
    Lewis, Rebecca
    Porta, Nuria
    Hussain, Syed A.
    James, Nicholas D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [6] Results of a phase III randomized trial of synchronous chemoradiotherapy (CRT) compared to radiotherapy (RT) alone in muscle-invasive bladder cancer (MIBC) (BC2001 CRUK/01/004)
    James, N. D.
    Hussain, S. A.
    Hall, E.
    Jenkins, P.
    Tremlett, J.
    Rawlings, C.
    Hendron, C.
    Lewis, R.
    Rogers, S.
    Huddart, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 Trial
    Hussain, Syed A.
    Porta, Nuria
    Hall, Emma
    Salawu, Abdulazeez
    Lewis, Rebecca
    Sreenivasan, Thiagarajan
    Wallace, Jan
    Crundwell, Malcolm
    Jenkins, Peter
    Tremlett, Jean
    Huddart, Robert
    James, Nicholas D.
    EUROPEAN UROLOGY, 2021, 79 (02) : 307 - 315
  • [8] Outcome of BC2001 patients (CRUK/01/004) who received neoadjuvant chemotherapy prior to randomization to chemo-radiotherapy (cRT) versus radiotherapy (RT).
    Hussain, Syed A.
    Hall, Emma
    Porta, Nuria
    Crundwell, Malcolm
    Jenkins, Peter
    Rawlings, Christine Lisa
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [9] Randomized Noninferiority Trial of Reduced High-Dose Volume Versus Standard Volume Radiation Therapy for Muscle-Invasive Bladder Cancer: Results of the BC2001 Trial (CRUK/01/004)
    Huddart, Robert A.
    Hall, Emma
    Hussain, Syed A.
    Jenkins, Peter
    Rawlings, Christine
    Tremlett, Jean
    Crundwell, Malcolm
    Adab, Fawzi A.
    Sheehan, Denise
    Syndikus, Isabel
    Hendron, Carey
    Lewis, Rebecca
    Waters, Rachel
    James, Nicholas D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : 261 - 269
  • [10] Re: Randomized Noninferiority Trial of Reduced High-Dose Volume versus Standard Volume Radiation Therapy for Muscle-Invasive Bladder Cancer: Results of the BC2001 Trial (CRUK/01/004) Editorial Comment
    Huddart, R. A.
    Hall, E.
    Hussain, S. A.
    Jenkins, P.
    Rawlings, C.
    Tremlett, J.
    Crundwell, M.
    Adab, F. A.
    Sheehan, D.
    Syndikus, I.
    Hendron, C.
    Lewis, R.
    Waters, R.
    James, N. D.
    JOURNAL OF UROLOGY, 2014, 191 (06): : 1731 - 1731
12345